Sales & Marketing The hidden IP problem holding innovators back For organisations active in the US market, the impact of patent marking is financial, not administrative.
R&D The Autumn Budget: What it means for UK life sciences deVere and Inventus comment on the UK Autumn Budget and what it means for life sciences in the country.
News £800m life sciences cluster opens in London In a boost for the UK life sciences sector, a new £800m life sciences hub located at Barts Health NHS Trust in London has been opened today.
News Sofinnova Partners raises €650m for early-stage biotechs European life sciences venture capital company Sofinnova Partners has closed its latest fund, Sofinnova Capital XI, raising €650 million.
News Medicxi raises €500m for latest biotech fund Medicxi closes its fifth round, raising €500m for 'asset-centric' firms at all stages of development and taking the total raised in 10 years to €2bn+.
News UK facing alarming loss of scientific talent overseas Two new reports suggest the UK is seeing an exodus of skilled STEM workers to other countries, placing the country's economic future at risk.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
